Tag Archives: COVID19

TipRanks The Bottom Is in for These 3 Stocks? Analysts Say ‘Buy’ Never say that one person makes no difference. This past Thursday, stocks tumbled, bonds surged, and investors started taking inflationary risks seriously – all because one guy said what he thinks. Jerome Powell, chair of the Federal Reserve, held a press conference at which he gave both the good and the bad. He stated, again, his belief that the COVID vaccination program will allow a full reopening of the economy, and that… Source link

A year into the pandemic, COVID-19 still puzzles researchers, but the public release of a new database may help scientists solve some of the mysteries lingering around this devastating disease. An international team of researchers from institutions including Boston Children’s Hospital, Northeastern University and the University of Oxford has partnered with Google.org, Google’s nonprofit subsidiary, to release Global.health, a platform that contains information about almost 10 million… Source link

A year into the pandemic, COVID-19 still puzzles researchers, but the public release of a new database may help scientists solve some of the mysteries lingering around this devastating disease. An international team of researchers from institutions including Boston Children’s Hospital, Northeastern University and the University of Oxford has partnered with Google.org, Google’s nonprofit subsidiary, to release Global.health, a platform that contains information about almost 10 million COVID-19… Source link

Airbnb’s (ABNB) first quarter as a public company was defined by the creative ways people have traveled during a pandemic. The rise in nearby road trips to more remote locations and longer term stays gave the home rental company a leg up compared to its counterparts in the traditional hospitality space. However, the upcoming availability of vaccinations raises the question of whether these adopted patterns will continue in a post-coronavirus world. “The lines between travel and living are… Source link

Johnson & Johnson’s (JNJ) single-dose COVID-19 vaccine was given an emergency use authorization (EAU) Saturday evening by U.S. Food and Drug Administration (FDA), making it the third vaccine available in the U.S. The Vaccines and Related Biologics Products Advisory Committee (VRBPAC) voted unanimously Friday to recommend use of the vaccine on adults aged 18 and older, based on all the data submitted by the company, and the vaccine was endorsed by FDA staff earlier in the week. J&J’s vaccine,… Source link

Over the past few months, all of the available data from clinical trials and real-world studies has shown the approved COVID-19 vaccines are safe and extremely effective. Experts have emphasized again and again the inoculation represents America’s only way out of the pandemic. According to a new Yahoo News/YouGov poll, most Americans have absorbed this message and become more likely to say they will get vaccinated since the vaccine rollout began in the wake of last year’s presidential… Source link

Moncada eyes return to 2019 form with COVID ‘struggle’ over originally appeared on NBC Sports Chicago Yoán Moncada let everyone in on his “daily battle” with the aftereffects of his COVID-19 infection last season. Even if he wanted to, he wouldn’t have been able to keep it a secret for long. He was running the bases one night in Cleveland, and after scoring and returning to the White Sox dugout, there he was, being fanned with a towel by manager Rick Renteria. It looked like it took everything… Source link

TipRanks Billionaire Ray Dalio Places Bet on 3 “Strong Buy” Stocks When billionaire financier Ray Dalio makes a move, Wall Street pays attention. Dalio, who got his start working on the floor of the New York Stock Exchange trading commodity futures, founded the world’s largest hedge fund, Bridgewater Associates, in 1975. With the firm managing about $140 billion in global investments and Dalio’s own net worth coming at $17 billion, he has earned legendary status on Wall Street. Summing… Source link

TipRanks The Bottom Is in for These 2 Stocks? Analysts Say ‘Buy’ Today, we’re looking at two small-cap biotech firms whose stocks have struck a rut. Each company has hit a recent clinical setback that sent the share price falling, erasing previous gains and sending it back down to low levels. Setbacks of this sort are not uncommon in the biotech industry, and in fact highlight the risk and speculative nature of the industry. So what should investors do, when a stock collapses? Is this a… Source link

TipRanks 2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon Let’s talk about risk and the big picture. It’s an appropriate time, as the big risk – presented by the COVID-19 pandemic – is finally receding thanks to the ongoing vaccination program. COVID is leaving behind an economy that was forced into shutdown one year ago while in the midst of a great expansion, boosted by the deregulation policies. While the new Biden Administration is busy reversing many Trump… Source link